SEC Filing | Option Care Health, Inc.

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

DENNESS RICHARD

(Last)

(First)

(Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, #300N

(Street)

BANNOCKBURN

60015

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CHIEF COMMERCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	10/21/2021		A		13,981		⁽²⁾	⁽²⁾	Common Stock, $.0001 Par Value	13,981	⁽¹⁾	13,981	D
Employee Stock Option (Right to Buy)	$25.75	10/21/2021		A		40,383		10/21/2024	10/21/2031	Common Stock, $.0001 Par Value	40,383	$0	40,383	D

Explanation of Responses:

1. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

2. All Restricted Stock Units granted in this award vest on October 21, 2024.

	/s/ Clifford E. Berman, attorney-in-fact for Mr. Denness	10/25/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

OCTOBER 25, 2021
POWER OF ATTORNEY

FOR SECTION 16 REPORTING OBLIGATIONS

KNOW ALL BY THESE PRESENTS, that the undersigned
hereby constitutes and appoints each of Michael
Shapiro, Clifford Berman and Michael Rude, signing
singly, the undersigned?s true and lawful
attorney-in-fact to: (i) execute for and on behalf
of the undersigned, in the undersigned?s capacity as
an officer and/or director and/or owner of greater
than 10% of the outstanding shares of common stock of
Option Care Health, Inc., a Delaware corporation
(the ?Company?), Forms 3, 4 and 5 (including any
amendments, supplements or exhibits thereto) in
accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;
(ii) do and perform any and all acts for and on
behalf of the undersigned which may be necessary
or desirable to complete and execute any such
Form 3, 4 or 5 (including any amendments,
supplements or exhibits thereto) and timely
file such form with the United States Securities
and Exchange Commission (the ?SEC?) and any stock
exchange or similar authority, including the
New York Stock Exchange, and including without
limitation the filing of a Form ID or any other
documents necessary or appropriate to enable the
undersigned to file the Form 3, 4 and 5
electronically with the SEC; (iii) seek or obtain,
as the undersigned?s representative and on the
undersigned?s behalf, information on transactions
in the Company?s securities from any third party,
including brokers, employee benefit plan
administrators and trustees, and the undersigned
hereby authorizes any such person to release any
such information to each of the undersigned?s
attorneys-in-fact appointed by this Power of
Attorney and ratifies any such release of
information; and (iv) take any other action
of any type whatsoever in connection with the
foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may approve
in such attorney-in-fact?s discretion.

The undersigned hereby grants to each such
attorney-in-fact full power and authority to do
and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as
the undersigned might or could do if personally
present, with full power of substitution or
revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such
attorney-in-fact?s substitute or substitutes,
shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers
herein granted. The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming,
any of the undersigned?s responsibilities to
comply with Section 16 of the Securities
Exchange Act of 1934.

This Power of Attorney shall remain in full
force and effect until the undersigned is no
longer required to file Forms 3, 4 and 5 with
respect to the undersigned?s holdings of and
transactions in securities issued by the
Company, unless earlier revoked by the
undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed as of
date first written above.


Signed and acknowledged:

/s/ Richard Denness
Richard Denness